Ardelyx Executive Liquidates Shares Under Pre-Arranged Trading Plan
Laura A. Williams, Ardelyx Inc.'s Chief Patient Officer, executed a series of transactions on June 18, 2026, involving the sale of 81,898 shares and the exercise of stock options. The transactions, conducted under a pre-arranged 10b5-1 trading plan adopted in March 2026, resulted in approximately $490,487 in sales and the acquisition of 31,000 shar…